{"Title": ["Here's Why Agenus Stock Jumped Higher Today", "Why Agenus Stock Took Flight in May", "AGEN, AGE To Battle Coronavirus, BCLI Awaits ALS Trial Data, FDA Delays Decision On NVS' Drug", "BUZZ-U.S. STOCKS ON THE MOVE-Raytheon, Planet Fitness, Lands End", "BUZZ-U.S. STOCKS ON THE MOVE-Virgin Galactic, Baozun, HollyFrontier", "BUZZ-U.S. STOCKS ON THE MOVE-Digital Ally, Marathon Patent, Aduro Biotech", "Agenus Says FDA Clears IND For Allogeneic INKT Therapy To Treat COVID-19 Patients", "Here's Why Agenus Rose as Much as 23.3% Today", "Here's Why Agenus Stock Jumped Higher Today", "3 Top Stocks Under $5 to Buy Now", "Top Pharma Stocks Under $5", "Agenus Inc (AGEN) Q4 2019 Earnings Call Transcript", "Health Care Sector Update for 03/10/2020: SPEX,AGEN,GSK,AYTU,ASRT", "Health Care Sector Update for 03/10/2020: AGEN,GSK,AYTU,ASRT", "These 14 Stocks Are Stupid Cheap", "Here's Why Agenus Tumbled Today", "Agenus Inc (AGEN) Q1 2020 Earnings Call Transcript", "A $20 Billion Sweet Spot in Biotech", "Agenus Inc (AGEN) Q3 2019 Earnings Call Transcript", "3 Cancer Treatment Stocks to Buy Right Now", "Agenus Inc (AGEN) Q2 2019 Earnings Call Transcript", "Agenus Inc (AGEN) Q1 2019 Earnings Call Transcript", "Health Care Sector Update for 05/09/2019: AMRX,BIO,AGEN,ABIO", "Health Care Sector Update for 05/09/2019: BIO,AGEN,ABIO", "Agenus Stock Rises Ahead of Investor Day Presentation", "Gilead Files sNDA for Label Expansion of HIV Therapy Descovy", "3 Top Growth Stocks to Buy Right Now", "Agenus Wins $7.5M Milestone Payment From Gilead, Stock Up", "Agenus Inc (AGEN) Q4 2018 Earnings Conference Call Transcript", "Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates", "Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy", "Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy", "Health Care Sector Update for 05/09/2019: ABIO, AGEN, ENDP, JNJ, PFE, ABT, MRK, AMGN", "Why Agenus Inc. Stock Took Flight in January", "Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat", "Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales?", "6 Top Gainers In Healthcare Sector (BIOC, AGEN, LPCN...)", "Agenus (AGEN) Surges: Stock Moves 9.4% Higher", "Why Agenus Stock Is Spiking Today", "All the Pre-JPM News Healthcare Investors Need to Know", "The 3 Oldest Members of Biotech's Billion-Burned Club", "3 Biotech Stocks That Are Too Cheap to Ignore", "Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal", "2 Beaten-Down Biotech Stocks That Look Like Bargains Now", "Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead", "Why Agenus Stock Is Soaring Today", "Mid-Day Update: Wall Street Extends Slump on Fed Disappointment", "Why Celgene, Agenus, and Incyte Jumped Today", "Here's Why Agenus Shares Rose as Much as 13.5% Today", "3 Biotech Stocks That Are Too Cheap to Ignore", "Agenus shares soar after cancer therapy deal with Gilead", "US Futures Inch Higher After Fed Move", "AGEN Soars On GILD Deal, FENC Rolling Ahead, AIMT Gaining Steam", "Gilead, Agenus sign deal to develop immuno-oncology therapies", "Mid-Day Market Update: Crude Oil Down Over 3%; Agenus Shares Spike Higher", "Mid-Afternoon Market Update: Dow Tumbles 400 Points; DBV Technologies Shares Plummet", "Why Is Agenus (AGEN) Up 11.6% Since Last Earnings Report?", "Here's Why Agenus Stock Popped 51.6% in November", "Agenus (AGEN) Q3 Loss Wider Than Expected, Pipeline in Focus", "Agenus (AGEN) Reports Q3 Loss, Tops Revenue Estimates", "Will Agenus (AGEN) Report Negative Earnings Next Week? What You Should Know", "Celyad (CYAD) Jumps: Stock Rises 6.8%", "Close Update: Wall Street Roiled By Possible Government Shutdown, Fed Policy Moves", "Health Care Sector Update for 09/21/2018: AGEN, XOMA, LLY, BGNE", "Health Care Sector Update for 09/21/2018: BGNE,XOMA,AGEN,INCY,MRK", "Agenus Receives Milestone Payment of $5 Million from Incyte", "Why Agenus' Stock Perked Up in August", "Agenus (AGEN) Continue to Surge Higher?", "Is Agenus Inc. Stock a Buy?", "Zacks.com featured highlights include: Dollar Tree, Agenus, Huntsman, ArcelorMittal and International Paper", "Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 6.7%", "Health Care Sector Update for 09/21/2018: AGEN, XOMA, LLY, BGNE", "Agenus' (AGEN) Q2 Loss Narrower Than Expected, Revenues Beat", "Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates", "Agenus (AGEN) Reports Narrower than Expected Loss in Q2", "Will Agenus (AGEN) Disappoint Investors This Earnings Season?", "Should Biotech Investors Fear Dilution?", "Agenus (AGEN) Down 1.5% Since Earnings Report: Can It Rebound?", "Step Beyond Bargain Hunting & Tap Rising P/E With 5 Stocks", "Agenus (AGEN) Delivering Well on Its Pipeline Candidates", "Agenus' (AGEN) Q2 Loss Narrower Than Expected, Revenues Beat", "Will Agenus (AGEN) Disappoint Investors This Earnings Season?", "Why Is Agenus (AGEN) Down 17.7% Since its Last Earnings Report?", "Agenus (AGEN) Q4 Loss Wider Than Expected, Revenues Miss", "Agenus (AGEN) Reports Wider than Expected Q4 Loss, Sales Miss", "Pre-Market Earnings Report for March 15, 2018 : DG, BTG, SHEN, ADAP, KPTI, GCO, TLP, AGEN, SUP, JILL, SND, SELB", "Is Agenus Inc. (AGEN) a Buy?", "Why Agenus Stock Spiked Tuesday", "What's in Store for Agenus (AGEN) This Earnings Season?", "Are Options Traders Betting on a Big Move in Agenus (AGEN) Stock?", "Is Agenus Inc. a Buy?", "Spectrum Pharmaceuticals Up 134% in 6 Months: Here's Why", "3 Biotech Stocks Start Healthy in \u201918: Will the Rally Last?", "BlackRock, Pier One Imports, Alkermes, Vertex Pharmaceuticals and Agenus highlighted as Zacks Bull and Bear of the Day", "4 Market-Beating Sector ETFs and Stocks", "Agenus Inc., (AGEN) Jumps: Stock Rises 11.4%", "Why Agenus Inc. Stock Sank in December", "Agenus (AGEN) Reports In Line Loss in Q3, Revenues Lag", "Keryx (KERX) Q3 Loss Wider Than Expected, Stock Declines", "Prothena (PRTA) Earnings Beat in Q3, Pipeline in Focus", "Agenus (AGEN) Reports In Line Q3 Loss, Sales Miss Estimates", "Endocyte (ECYT) Posts Narrower-than-Expected Q3 Loss", "Will 2018 Be Agenus Inc.'s Best Year Yet?", "What's in the Cards for Merrimack (MACK) in Q3 Earnings?", "What's in the Cards for Repros (RPRX) This Earnings Season?", "What's in Store for Ligand (LGND) This Earnings Season?", "What's in Store for Madrigal (MDGL) This Earnings Season?", "Inovio (INO) Q3 Earnings: Is a Beat in Store for the Stock?", "Ironwood (IRWD) Beats Estimates in Q3 Earnings, Stock Up", "Is a Beat in the Cards for Perrigo (PRGO) in Q3 Earnings?", "What's in Store for Catalyst (CPRX) This Earnings Season?", "Spectrum (SPPI) Earnings, Sales Beat Q3 Estimates", "Corcept (CORT) Q3 Earnings Miss Estimates, Guidance Raised", "Horizon Pharma (HZNP) Q3 Earnings: A Disappointment in Store? (revised)", "Epizyme (EPZM) Reports Narrower-than-Expected Loss in Q3", "Zoetis (ZTS) Beats on Q3 Earnings & Sales, Ups 2017 View", "Geron (GERN) Q3 Loss Narrower Than Expected, Sales Miss", "Sucampo (SCMP) Beats on Q3 Earnings & Revenues, Ups '17 View", "AMAG Pharma's (AMAG) Q3 Earnings Beat, Lowers '17 Outlook", "Dr. Reddy's (RDY) Q2 Earnings and Revenues Decline Y/Y", "Is a Beat in Store for Ionis (IONS) This Earnings Season?", "Novo Nordisk (NVO) Tops Q3 Earnings Estimates, Lags Sales", "Will Endocyte (ECYT) Disappoint This Earnings Season?", "Jazz Pharmaceuticals (JAZZ) Q3 Earnings: A Beat in Store?", "Is a Beat in the Cards for Mylan (MYL) This Earnings Season?", "What's in the Cards for Prothena (PRTA) in Q3 Earnings?", "Horizon Pharma (HZNP) Q3 Earnings: A Disappointment in Store?", "Is a Beat in Store for Zoetis (ZTS) This Earnings Season?", "Is a Turnaround in Store for Teva (TEVA) in Q3 Earnings?", "What's in the Cards for Immune Design (IMDZ) in Q3 Earnings?", "What's in the Offing for Intercept (ICPT) in Q3 Earnings?", "What's in Store for Juno Therapeutics (JUNO) in Q3 Earnings?", "What's in the Cards for Arena (ARNA) This Earnings Season?", "What to Expect from Keryx (KERX) This Earnings Season?", "Alkermes (ALKS) Beats Q3 Earnings Estimates, Cuts Sales View", "Sarepta (SRPT) Q3 Loss Narrows, Exondys 51 Sales View Raised", "Is a Beat in Store for Agenus (AGEN) This Earnings Season?", "Why Agenus Inc. Stock Briefly Popped Today", "Why Agenus Inc. Stock Slumped Today", "Agenus (AGEN) Remains Focused on Drug Development Programs", "Another 'Picks And Shovels' Nasdaq Stock With Massive Potential", "Is a Beat in the Cards for ImmunoGen (IMGN) in Q3 Earnings?", "3 Top Biotech Stocks Under $5", "3 Beaten-Up Biotech Stocks: Are They Bargains?", "Agenus (AGEN) Q2 Loss Narrower Than Expected, Revenues Lag", "Here's Why Agenus Inc. Stock Slipped 13.6% in July", "Agenus (AGEN) Reports Narrower-than-Expected Q2 Loss", "Sucampo (SCMP) Q2 Earnings & Revenues Beat Estimates, Up Y/Y", "Exact Sciences Corporation (EXAS) Jumps: Stock Rises 6.2%", "Why Is Agenus (AGEN) Down 11.8% Since the Last Earnings Report?", "What's in Store for Endocyte (ECYT) this Earnings Season?", "New Strong Buy Stocks for July 26th", "What to Expect from International Paper (IP) in Q2 Earnings?", "S&P Global (SPGI) to Post Q2 Earnings: A Beat in the Cards?", "VASCO (VDSI) to Report Q2 Earnings: What's in the Offing?", "Is a Beat in Store for Agenus (AGEN) this Earnings Season?", "What to Expect from Keryx (KERX) this Earnings Season?", "Did the Checkpoint Inhibitor Bubble Just Burst?", "New Strong Buy Stocks for July 20th", "uniQure N.V. (QURE) Shows Strength: Stock Moves 9.1% Higher", "Agenus (AGEN) Catches Eye: Stock Moves Up 8.7% in Session", "Eiger BioPharmaceuticals (EIGR) Rises: Stock Climbs 24%", "3 Stocks That Are Ridiculously Cheap Right Now", "Alexion Reportedly Being Investigated by HHS, Shares Slip", "VIVUS Settles with Teva on Weight Management Drug Generic", "Is a Beat in Store for Alexion (ALXN) this Earnings Season?", "New Strong Buy Stocks for July 20th", "Better Buy: Agenus Inc. vs. Kite Pharma", "Agenus (AGEN) Looks Good: Stock Moves Up 9.6% in Session", "Tuesday's ETF Movers: XBI, IXC", "Agenus (AGEN) Down 15.7% Since Earnings Report: Can It Rebound?", "3 Stocks With Exelixis-Like Return Potential", "Noteworthy Tuesday Option Activity: GOOG, PANW, AGEN", "Geron Stock Up Almost 40% So Far This Year After '16 Decline", "Is the Options Market Predicting a Spike in Agenus (AGEN) Stock?", "Here's Why Agenus Inc. Stock Is Climbing Today", "What's in Store for Agenus (AGEN) this Earnings Season?", "Thursday's ETF Movers: XBI, GDXJ", "Thursday 4/13 Insider Buying Report: HESM, AGEN", "Why Is Agenus (AGEN) Down 16.8% Since the Last Earnings Report?", "Better Buy: Celldex Therapeutics, Inc. vs. Agenus Inc.", "4 Biotech Stocks With Jaw-Dropping Growth Potential", "Agenus (AGEN) Reports Narrower-than-Expected Loss in Q4", "Better Buy: Agenus Inc. vs. Celldex Therapeutics", "Agenus (AGEN) Reports Narrower-than-Expected Q4 Loss", "Agenus (AGEN): What's Ahead for the Stock in Q4 Earnings?", "Troubling Trial Data Weighed on Agenus Inc Stock Today", "Agenus (AGEN) Sharpens Focus on Drug Development Programs", "Health Care Sector Update for 02/14/2017: INCY,AGEN,CYNO,HOLX,AVIR", "3 Growth Stocks That Could Double", "Better Buy: Agenus Inc. vs. Alnylam Pharmaceuticals, Inc.", "Forget Celldex Therapeutics, Inc.: These 2 Stocks Are Better Buys", "Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo", "3 Beaten-Up Biotech Stocks: Are They Bargains?", "Agenus' INCAGN1876 in Phase I/II Study for Solid Tumors", "Why Agenus Stock Is Surging Today", "Why Agenus Inc. Stock Plummeted 44.7% in October", "Agenus (AGEN) Reports Wider-than-Expected Loss in Q3", "Agenus (AGEN) Reports Narrower-than-Expected Q3 Loss", "Why Fret Over Agenus Inc. Q3 Results?", "Agenus (AGEN): What's Ahead for the Stock in Q3 Earnings?", "Better Buy: Agenus Inc. vs. Bellicum Pharmaceuticals Inc.", "Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company", "3 Red Flags on Agenus Inc's Balance Sheet", "CAR-T Isn't the Only Play in Immunotherapy Stocks", "2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now", "Why Agenus (AGEN) Stock Might be a Great Pick", "Intercept (ICPT) Reports Narrower-than-Expected Q2 Loss", "Will Agenus (AGEN) Continue to Surge Higher?", "Geron (GERN) Posts Narrower-Than-Expected Loss in Q2", "Aerie (AERI) Q2 Loss Wider than Expected, Pipeline in Focus", "Are These 3 Clinical-Stage Biotechs Still Buys After Soaring in August?", "7 Biotech Stocks With Pivotal Catalysts in 2017", "Agenus (AGEN) Posts Narrower than Expected Loss in Q2", "Agenus (AGEN) Reports Narrower-than-Expected Q2 Loss", "Agenus (AGEN): What's Ahead for the Stock in Q2 Earnings?", "Is Agenus or Ariad Pharmaceuticals the Better Long-Term Buy?", "Why Agenus' Stock Has Stumbled in 2016", "Better Buy: Agenus Inc. vs. bluebird bio", "Abeona Therapeutics (ABEO) in Focus: Stock Up 5.7% in Session", "2 Biotech Stocks Under $5 With Jaw-Dropping Growth Potential", "Thursday 5/12 Insider Buying Report: MATR, AGEN", "Agenus' (AGEN) Q1 Loss Wider than Expected, Revenue Miss", "Agenus (AGEN) Reports Wider-than-Expected Q1 Loss", "Either Analysts Got The Components Wrong or Russell 2000 Headed 12% Higher", "Drug Stocks' Earnings Previews: KERX, BXLT, BMRN, AGEN, IMGN", "Agenus (AGEN) Q1 Earnings: What's in Store for the Stock?", "Should Pfizer Buy This Beaten-Down Immuno-Oncology Company?", "Why Agenus Inc. Is Flying High Today", "Agenus' Q4 Loss in Line with Estimates, Revenues Impress", "New Strong Buy Stocks for March 4th", "3 Stocks That Could Double Your Money", "Agenus Reports Loss, Beats on Revenues", "Forget Organovo Holdings Inc.: These 2 Stocks Are Better Buys", "What's in Store for Agenus (AGEN) This Earnings Season?", "Why Agenus Inc. Stock Soared 43% in March", "Agenus (AGEN) Catches Eye: Stock Adds 8.8% in Session", "Why Shares of Agenus Are Breaking Out Today", "Big Firms Love This Little Biotech", "Agenus Acquires PhosImmune, Adds Cancer Neoantigens", "3 Biotech Stocks Under $5 That Could Explode Higher in 2016", "3 Stocks We Like -- but Not for Retirees", "Wednesday's ETF Movers: XBI, ILF", "How I'd Invest $500 Today", "Agenus Q3 Loss Wider than Expected, Pipeline in Focus", "Agenus' (AGEN) Q3 Loss is Wider-than-Expected", "Will Agenus (AGEN) Disappoint Yet Again in Q3 Earnings?", "Wednesday 9/30 Insider Buying Report: AGEN, JMP", "Don't Panic! These 3 Beaten Down Biotech Stocks Are Now Great Buys", "Friday's ETF with Unusual Volume: XBI", "Friday's ETF Movers: RWX, XBI", "Why XOMA Shares Are Crashing", "New Strong Sell Stocks for September 22nd", "Why Agenus' Stock Tumbled in August", "Wall Street Can\u2019t Get Enough of This Speculative Biotech Stock", "Incyte & Hengrui to Develop Anti-PD-1 Monoclonal Antibody", "3 Low-Price Biotech Stocks That Could Pop or Drop in 2016", "Agenus (AGEN) Reports Wider-than-Expected Q2 Loss - Tale of the Tape", "Will Agenus (AGEN) Disappoint Investors this Earnings? - Analyst Blog", "Friday Sector Laggards: Metals & Mining, Biotechnology Stocks", "Why Agenus (AGEN) Could Be Positioned for a Surge? - Tale of the Tape", "Cancer Drugs: 2 Stocks to Watch", "Agenus Gains after Merck Extends Immuno-Oncology Ties - Analyst Blog", "Agenus (AGEN) Provides Update on its Brain Cancer Vaccine - Analyst Blog", "Why Agenus Inc. Shares Surged Higher In Early Trading Today", "Why Agenus Inc. Shares Are Soaring Today", "Eli Lilly Beats on 1Q Earnings by Wide Margin, Affirms View - Analyst Blog", "These 2 Stocks Doubled in 2015 -- Is 1 Still a Buy?", "Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?", "Will Agenus (AGEN) Continue to Surge Higher? - Tale of the Tape", "Will Agenus (AGEN) Disappoint in Q1 Earning Season? - Analyst Blog", "3 Stocks That Could Double Your Money", "Why It's Not Too Late to Buy Agenus, Inc. Stock", "Agenus (AGEN) Reports Wider-than-Expected Q4 Loss - Tale of the Tape", "Notable option trades in equities", "Agenus (AGEN) Reports Wider-than-Expected Q1 Loss - Tale of the Tape", "AstraZeneca Inks Immuno-Oncology Agreement with Omnis - Analyst Blog", "Agenus (AGEN) Worth Watching: Stock Soars 28.7% - Tale of the Tape", "Agenus Soars on Immuno-Oncology Agreement with Incyte - Analyst Blog", "Cancel JPMorgan! Plenty of Pre-Conference Data and Deals to Digest", "Mid-Morning Market Update: Markets Decline; Infosys Posts Higher Profit", "US Stock Futures Edge Up After More Than Expected Jobs Added to Economy, Unemployment Drops to 5.6%", "US Futures Slip Ahead of Jobs Report", "Agenus (AGEN) Shares March Higher, Can It Continue? - Tale of the Tape", "AstraZeneca Inks Immuno-Oncology Agreement with Omnis - Analyst Blog", "Mid-Day Market Update: Dow Dips 1%; Acuity Brands Shares Jump On Earnings Beat", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Agenus (AGEN) Shares March Higher, Can It Continue? - Tale of the Tape", "Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Mid-Afternoon Market Update: Five Below Slips On Weak Outlook; Agenus Shares Spike Higher", "Fate Therapeutics (FATE) Catches Eye: Stock Adds 6.4% in Session - Tale of the Tape", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Keryx (KERX) in Focus: Stock Adds 11.9% in Session - Tale of the Tape", "Genomic Health Q3 Loss Narrower than Expected, Revenues Lag - Analyst Blog", "Cytokinetics, Incorporated (CYTK) in Focus: Stock Surges 16.2% - Tale of the Tape", "Achillion Pharmaceuticals Slumps: ACHN Plunges 15.6% in Session - Tale of the Tape", "Integra Beats Earnings, Sales Up Y/Y, Outlook Lowered - Analyst Blog", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Will Agenus (AGEN) Incur Wider-than-Expected Q3 Loss? - Analyst Blog", "Why Agenus (AGEN) Could Be Positioned for a Slump - Tale of the Tape", "Agenus Inc. (AGEN) Looks Strong as Stock Surges 11.15% - Tale of the Tape", "Sector Update: Health-Care Shares Higher Pre-Market", "Sector Update: Health Care", "BioDelivery Sciences International (BDSI) Rises: Stock Jumps 8.9% - Tale of the Tape", "Oncolytics Biotech Inc. (ONCY) in Focus: Stock Rises 9.5% - Tale of the Tape", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Synta Pharmaceuticals (SNTA) Jumps: Stock Rises 7.9% - Tale of the Tape", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Agenus Up on Positive Prophage Data - Analyst Blog", "Geron Corp. (GERN) Jumps: Stock Moves 8.1% Higher - Tale of the Tape", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Sector Update: Shares Flat Pre-Market; Agenus Soars 21% on Phase 2 Trial", "Sector Update: Healthcare", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Synta Pharmaceuticals (SNTA) Jumps: Stock Rises 7.9% - Tale of the Tape", "Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape", "bluebird bio (BLUE) Jumps: Stock Adds 27.3% in Session - Tale of the Tape", "Celldex Therapeutics (CLDX) Soars: Stock Adds 26.9% in Session - Tale of the Tape", "Stock Market News for April 29, 2014 - Market News", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Sector Update: Healthcare Shares Flat Pre-Market; Acorda Could File Patent Infringement Suit", "Positive Results on Intercept Pharma's OCA - Analyst Blog", "Sector Update: Healthcare Shares Higher Pre-Market; Agenus Sinks 9% As GlaxcoSmithKline Halts Study", "Sector Update: Healthcare", "Agenus (AGEN) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape", "Biotech Stock Roundup: GILD Letter Triggers Major Selloff - Analyst Blog", "Why Agenus (AGEN) Might Be a Diamond in the Rough - Tale of the Tape", "Glaxo's MAGE-A3 Candidate Disappoints Again - Analyst Blog", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Agenus (AGEN) Jumps: Stock Adds 8.8% in Session - Tale of the Tape", "Agenus (AGEN) Soars: Stock Adds 12.7% in Session - Tale of the Tape", "Healthcare Stocks Slightly Higher; Agenus Adds 20% on Positive Test Results for Prospective Cancer Vaccine", "Sector Update: Healthcare", "Transition Therapeutics (TTHI) Jumps: Stock Adds 7.0% in Session - Tale of the Tape", "Sector Update: Healthcare", "Sector Update: Healthcare Shares Mixed: NovaBay Sheds More than 50% on Failure to Meet Endpoint", "Agenus: Acquisition Of 4-Antibody Is A Transformational Move", "Acorda's GGF2 in Another Study - Analyst Blog", "Sector Update: Healthcare Shares Flat; Agenus up 10% on Malaria Vaccine Data", "Sector Update: Healthcare", "Acorda Progresses with Pipeline - Analyst Blog", "Halozyme (HALO) in Focus: Stock Rises 6.9% - Analyst Blog", "Agenus Raises Funds - Analyst Blog", "Positive Results on Agenus Candidate - Analyst Blog", "QIAGEN Aids Genome Sequencing Study - Analyst Blog", "Sector Update: Healthcare Shares Flat; Agenus Rallies 22% on Phase 2 Cancer Treatment Study", "Sector Update: Healthcare", "Agenus: Upcoming MAGE A-3 Clinical Trial Results Will Have A Major Impact On The Stock", "Agenus: Key Clinical Events Are Imminent", "Data on ArQule's ARQ 092 - Analyst Blog", "Spectrum Progresses with SPI-2012 - Analyst Blog", "Acorda Reports Data on Epilepsy Drug - Analyst Blog", "Agenus: Thoughts On Phase II Results For Prophage In Glioblastoma", "XOMA Posts Narrower Loss - Analyst Blog", "Spectrum Guides Lower 2013 Revenue - Analyst Blog", "Update on Elan's Plans - Analyst Blog", "Acorda Presents GGF2 Data - Analyst Blog", "Narrower-Than-Expected Loss at OSIR - Analyst Blog", "Elan to Share Tysabri Proceeds - Analyst Blog", "Aegerion Incurs Wider Loss - Analyst Blog", "SPPI Acquires Late-Stage Candidate - Analyst Blog", "Wider Loss at InterMune - Analyst Blog", "Savient to Promote Sobi's Kineret - Analyst Blog", "ALIOF Candidate Approved in Japan - Analyst Blog", "Zacks Rank #1 Addition for Thursday - Tale of the Tape", "ImmunoGen Progresses with IMGN901 - Analyst Blog", "Zacks Rank #1 Addition for Monday - Tale of the Tape", "SGEN Starts SGN-CD19A Phase I Study - Analyst Blog", "Vertex Flu Drug Shows Promise - Analyst Blog", "Data on Anacor Candidate - Analyst Blog", "Threshold/Merck KGaA Drug in Study - Analyst Blog", "Zacks Rank #1 Addition for Monday - Tale of the Tape", "Cadence Forecasts Ofirmev Sales - Analyst Blog", "SGEN/Takeda's Adcetris Progresses - Analyst Blog", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Zacks Rank #1 Additions for Friday - Tale of the Tape", "Zacks Rank #1 Addition for Wednesday - Tale of the Tape", "Zacks #1 Rank Additions for Monday - Tale of the Tape", "Celgene Remains Neutral - Analyst Blog", "Positive Results on MDCO's Cangrelor - Analyst Blog", "Update on Orexigen's Contrave - Analyst Blog", "BioMarin Takes Over Zacharon - Analyst Blog", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Zacks #1 Rank Additions for Monday - Tale of the Tape", "InterMune to Raise Funds - Analyst Blog", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Pre-Market Earnings Report for August 2, 2012 : APA, AEE, ANSS, ARIA, APO, ALE, AB, ABMD, AYR, AVD, ARQL, AGEN", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Zacks #1 Rank Additions for Monday - Tale of the Tape", "Biotech Ideas: Top Biotech Stocks with Bullish Institutional Trends", "The Cancer Conference Trade: Picking Up Biotech Bargains", "Four Biotech Stocks to Play the Sector Pullback", "A Company's First Profit Can Mean Big Gains for Investors - Screen of the Week"], "Elapsed Time": ["3 DAYS AGO", "JUN 8, 2020", "JUN 3, 2020", "JUN 2, 2020", "JUN 2, 2020", "JUN 2, 2020", "JUN 2, 2020", "MAY 29, 2020", "3 DAYS AGO", "APR 24, 2020", "MAR 24, 2020", "MAR 12, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 8, 2020", "FEB 20, 2020", "MAY 8, 2020", "DEC 28, 2019", "NOV 4, 2019", "OCT 10, 2019", "AUG 10, 2019", "MAY 10, 2019", "MAY 9, 2019", "MAY 9, 2019", "FEB 19, 2020", "APR 8, 2019", "MAR 20, 2019", "MAR 14, 2019", "MAR 14, 2019", "MAR 14, 2019", "MAR 8, 2019", "MAR 7, 2019", "MAY 9, 2019", "FEB 8, 2019", "FEB 5, 2019", "JAN 31, 2019", "JAN 17, 2019", "JAN 8, 2019", "JAN 7, 2019", "JAN 6, 2019", "MAR 3, 2019", "DEC 26, 2018", "DEC 26, 2018", "DEC 23, 2018", "DEC 21, 2018", "DEC 20, 2018", "DEC 20, 2018", "JAN 3, 2019", "JAN 3, 2019", "DEC 26, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 6, 2018", "DEC 5, 2018", "NOV 8, 2018", "NOV 6, 2018", "OCT 30, 2018", "OCT 5, 2018", "DEC 20, 2018", "SEP 21, 2018", "SEP 21, 2018", "SEP 18, 2018", "SEP 7, 2018", "AUG 31, 2018", "AUG 23, 2018", "AUG 17, 2018", "OCT 4, 2018", "SEP 21, 2018", "AUG 10, 2018", "AUG 9, 2018", "AUG 9, 2018", "JUL 30, 2018", "JUL 21, 2018", "JUN 6, 2018", "AUG 16, 2018", "AUG 15, 2018", "AUG 10, 2018", "APR 30, 2018", "APR 16, 2018", "MAR 16, 2018", "MAR 15, 2018", "MAR 14, 2018", "MAY 12, 2018", "FEB 21, 2018", "FEB 21, 2018", "FEB 13, 2018", "FEB 13, 2018", "JAN 19, 2018", "JAN 18, 2018", "JAN 17, 2018", "FEB 28, 2018", "JAN 9, 2018", "JAN 6, 2018", "NOV 8, 2017", "NOV 8, 2017", "NOV 8, 2017", "NOV 7, 2017", "NOV 7, 2017", "JAN 16, 2018", "NOV 6, 2017", "NOV 6, 2017", "NOV 6, 2017", "NOV 6, 2017", "NOV 6, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 6, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 2, 2017", "NOV 2, 2017", "NOV 2, 2017", "NOV 2, 2017", "NOV 2, 2017", "NOV 3, 2017", "NOV 1, 2017", "NOV 1, 2017", "NOV 1, 2017", "OCT 31, 2017", "OCT 31, 2017", "OCT 31, 2017", "OCT 31, 2017", "NOV 2, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 31, 2017", "OCT 27, 2017", "OCT 26, 2017", "OCT 25, 2017", "OCT 23, 2017", "OCT 19, 2017", "SEP 28, 2017", "SEP 14, 2017", "OCT 30, 2017", "AUG 19, 2017", "AUG 14, 2017", "AUG 4, 2017", "AUG 4, 2017", "AUG 3, 2017", "AUG 3, 2017", "JUL 27, 2017", "SEP 5, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 24, 2017", "JUL 21, 2017", "JUL 27, 2017", "JUL 20, 2017", "JUL 20, 2017", "JUL 19, 2017", "JUL 17, 2017", "JUL 16, 2017", "JUL 7, 2017", "JUL 6, 2017", "JUL 20, 2017", "JUL 20, 2017", "JUL 2, 2017", "JUN 21, 2017", "JUN 20, 2017", "JUN 8, 2017", "JUN 5, 2017", "MAY 30, 2017", "JUL 5, 2017", "JUL 3, 2017", "MAY 4, 2017", "APR 24, 2017", "APR 13, 2017", "APR 13, 2017", "APR 11, 2017", "MAY 21, 2017", "MAR 21, 2017", "MAR 10, 2017", "MAR 10, 2017", "MAR 9, 2017", "FEB 27, 2017", "FEB 22, 2017", "APR 5, 2017", "FEB 14, 2017", "FEB 8, 2017", "FEB 6, 2017", "FEB 1, 2017", "JAN 18, 2017", "DEC 9, 2016", "DEC 1, 2016", "FEB 14, 2017", "NOV 7, 2016", "OCT 28, 2016", "OCT 27, 2016", "OCT 27, 2016", "OCT 24, 2016", "OCT 18, 2016", "SEP 27, 2016", "NOV 23, 2016", "SEP 7, 2016", "AUG 18, 2016", "AUG 12, 2016", "AUG 8, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 4, 2016", "SEP 9, 2016", "AUG 2, 2016", "JUL 29, 2016", "JUL 28, 2016", "JUL 25, 2016", "JUL 19, 2016", "JUN 27, 2016", "JUN 24, 2016", "AUG 3, 2016", "MAY 30, 2016", "MAY 12, 2016", "APR 29, 2016", "APR 28, 2016", "APR 28, 2016", "APR 27, 2016", "APR 25, 2016", "JUN 14, 2016", "MAR 11, 2016", "MAR 4, 2016", "MAR 4, 2016", "MAR 3, 2016", "MAR 3, 2016", "MAR 1, 2016", "FEB 23, 2016", "APR 11, 2016", "JAN 22, 2016", "JAN 21, 2016", "JAN 3, 2016", "DEC 28, 2015", "DEC 27, 2015", "DEC 5, 2015", "NOV 25, 2015", "FEB 13, 2016", "OCT 28, 2015", "OCT 27, 2015", "OCT 26, 2015", "SEP 30, 2015", "SEP 29, 2015", "SEP 25, 2015", "SEP 25, 2015", "NOV 6, 2015", "SEP 22, 2015", "SEP 10, 2015", "SEP 3, 2015", "SEP 3, 2015", "AUG 21, 2015", "JUL 23, 2015", "JUL 21, 2015", "SEP 25, 2015", "JUN 29, 2015", "JUN 7, 2015", "JUN 4, 2015", "MAY 15, 2015", "APR 28, 2015", "APR 24, 2015", "APR 23, 2015", "JUL 18, 2015", "APR 22, 2015", "APR 22, 2015", "APR 22, 2015", "APR 19, 2015", "MAR 31, 2015", "FEB 26, 2015", "FEB 9, 2015", "APR 23, 2015", "JAN 14, 2015", "JAN 12, 2015", "JAN 12, 2015", "JAN 10, 2015", "JAN 9, 2015", "JAN 9, 2015", "JAN 9, 2015", "JAN 16, 2015", "JAN 14, 2015", "JAN 9, 2015", "DEC 29, 2014", "DEC 19, 2014", "DEC 19, 2014", "DEC 8, 2014", "JAN 9, 2015", "NOV 19, 2014", "NOV 18, 2014", "NOV 7, 2014", "NOV 6, 2014", "NOV 5, 2014", "NOV 5, 2014", "NOV 4, 2014", "NOV 20, 2014", "OCT 22, 2014", "AUG 5, 2014", "JUL 25, 2014", "JUL 24, 2014", "JUL 24, 2014", "JUL 8, 2014", "JUL 8, 2014", "NOV 3, 2014", "JUL 7, 2014", "JUL 3, 2014", "JUL 2, 2014", "JUL 1, 2014", "JUL 1, 2014", "JUL 1, 2014", "JUL 1, 2014", "JUL 7, 2014", "JUL 7, 2014", "MAY 16, 2014", "MAY 15, 2014", "MAY 15, 2014", "APR 29, 2014", "APR 24, 2014", "JUN 26, 2014", "APR 14, 2014", "APR 2, 2014", "APR 2, 2014", "MAR 28, 2014", "MAR 26, 2014", "MAR 24, 2014", "MAR 21, 2014", "APR 21, 2014", "JAN 10, 2014", "DEC 17, 2013", "DEC 16, 2013", "DEC 16, 2013", "NOV 27, 2013", "NOV 7, 2013", "NOV 7, 2013", "FEB 20, 2014", "OCT 14, 2013", "OCT 8, 2013", "OCT 8, 2013", "SEP 30, 2013", "SEP 30, 2013", "SEP 26, 2013", "SEP 18, 2013", "OCT 16, 2013", "SEP 17, 2013", "SEP 17, 2013", "AUG 21, 2013", "JUL 17, 2013", "APR 10, 2013", "APR 9, 2013", "MAR 26, 2013", "SEP 18, 2013", "MAR 14, 2013", "MAR 13, 2013", "MAR 11, 2013", "MAR 8, 2013", "MAR 7, 2013", "MAR 7, 2013", "MAR 7, 2013", "MAR 18, 2013", "FEB 22, 2013", "FEB 21, 2013", "FEB 20, 2013", "FEB 14, 2013", "FEB 14, 2013", "FEB 11, 2013", "FEB 7, 2013", "MAR 6, 2013", "JAN 30, 2013", "JAN 29, 2013", "JAN 28, 2013", "JAN 25, 2013", "JAN 25, 2013", "JAN 24, 2013", "JAN 18, 2013", "FEB 6, 2013", "JAN 14, 2013", "JAN 14, 2013", "JAN 10, 2013", "JAN 10, 2013", "JAN 10, 2013", "JAN 8, 2013", "DEC 10, 2012", "JAN 16, 2013", "DEC 4, 2012", "NOV 27, 2012", "NOV 13, 2012", "NOV 9, 2012", "NOV 1, 2012", "OCT 26, 2012", "AUG 1, 2012", "DEC 6, 2012", "MAY 17, 2012", "MAY 14, 2012", "JAN 9, 2012", "JUL 21, 2011", "NOV 3, 2009", "JUL 17, 2012"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/heres-why-agenus-stock-jumped-higher-today-2020-06-22", "https://www.nasdaq.com/articles/why-agenus-stock-took-flight-in-may-2020-06-08", "https://www.nasdaq.com/articles/agen-age-to-battle-coronavirus-bcli-awaits-als-trial-data-fda-delays-decision-on-nvs-drug", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-raytheon-planet-fitness-lands-end-2020-06-02", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-virgin-galactic-baozun-hollyfrontier-2020-06-02", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-digital-ally-marathon-patent-aduro-biotech-2020-06-02", "https://www.nasdaq.com/articles/agenus-says-fda-clears-ind-for-allogeneic-inkt-therapy-to-treat-covid-19-patients-2020-06", "https://www.nasdaq.com/articles/heres-why-agenus-rose-as-much-as-23.3-today-2020-05-29", "https://www.nasdaq.com/articles/heres-why-agenus-stock-jumped-higher-today-2020-06-22", "https://www.nasdaq.com/articles/3-top-stocks-under-%245-to-buy-now-2020-04-24", "https://www.nasdaq.com/articles/top-pharma-stocks-under-%245-2020-03-24", "https://www.nasdaq.com/articles/agenus-inc-agen-q4-2019-earnings-call-transcript-2020-03-13", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-10-2020%3A-spexagengskaytuasrt-2020-03-10", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-10-2020%3A-agengskaytuasrt-2020-03-10", "https://www.nasdaq.com/articles/these-14-stocks-are-stupid-cheap-2020-03-08", "https://www.nasdaq.com/articles/heres-why-agenus-tumbled-today-2020-02-20", "https://www.nasdaq.com/articles/agenus-inc-agen-q1-2020-earnings-call-transcript-2020-05-08", "https://www.nasdaq.com/articles/a-%2420-billion-sweet-spot-in-biotech-2019-12-28", "https://www.nasdaq.com/articles/agenus-inc-agen-q3-2019-earnings-call-transcript-2019-11-04", "https://www.nasdaq.com/articles/3-cancer-treatment-stocks-to-buy-right-now-2019-10-10", "https://www.nasdaq.com/articles/agenus-inc-agen-q2-2019-earnings-call-transcript-2019-08-10", "https://www.nasdaq.com/articles/agenus-inc-agen-q1-2019-earnings-call-transcript-2019-05-10", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-09-2019%3A-amrxbioagenabio-2019-05-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-09-2019%3A-bioagenabio-2019-05-09", "https://www.nasdaq.com/articles/agenus-stock-rises-ahead-of-investor-day-presentation-2020-02-19", "https://www.nasdaq.com/articles/gilead-files-snda-for-label-expansion-of-hiv-therapy-descovy-2019-04-08-0", "https://www.nasdaq.com/articles/3-top-growth-stocks-buy-right-now-2019-03-20", "https://www.nasdaq.com/articles/agenus-wins-%247.5m-milestone-payment-from-gilead-stock-up-2019-03-14", "https://www.nasdaq.com/articles/agenus-inc-agen-q4-2018-earnings-conference-call-transcript-2019-03-14", "https://www.nasdaq.com/articles/agenus-agen-reports-q4-loss-lags-revenue-estimates-2019-03-14", "https://www.nasdaq.com/articles/gilead-reports-positive-data-on-hiv-drugs-biktarvy-descovy-2019-03-08", "https://www.nasdaq.com/articles/gilead-reports-positive-data-on-hiv-drugs-biktarvy-descovy-2019-03-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-09-2019%3A-abio-agen-endp-jnj-pfe-abt-mrk-amgn-2019-05-09", "https://www.nasdaq.com/articles/why-agenus-inc-stock-took-flight-january-2019-02-08", "https://www.nasdaq.com/articles/gilead-gild-q4-earnings-miss-estimates-revenues-beat-2019-02-05", "https://www.nasdaq.com/articles/will-gilead-gild-q4-earnings-disappoint-on-weak-hcv-sales-2019-01-31", "https://www.nasdaq.com/articles/6-top-gainers-healthcare-sector-bioc-agen-lpcn-2019-01-17", "https://www.nasdaq.com/articles/agenus-agen-surges%3A-stock-moves-9.4-higher-2019-01-08", "https://www.nasdaq.com/articles/why-agenus-stock-spiking-today-2019-01-07", "https://www.nasdaq.com/articles/all-pre-jpm-news-healthcare-investors-need-know-2019-01-06", "https://www.nasdaq.com/articles/3-oldest-members-biotechs-billion-burned-club-2019-03-03", "https://www.nasdaq.com/articles/3-biotech-stocks-are-too-cheap-ignore-2018-12-26", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-acor-drugs-get-fda-nod-agen-up-on-gild-deal-2018-12-26", "https://www.nasdaq.com/articles/2-beaten-down-biotech-stocks-look-bargains-now-2018-12-23", "https://www.nasdaq.com/articles/agenus-stock-up-23-on-immuno-oncology-deal-with-gilead-2018-12-21", "https://www.nasdaq.com/articles/why-agenus-stock-soaring-today-2018-12-20", "https://www.nasdaq.com/articles/mid-day-update-wall-street-extends-slump-fed-disappointment-2018-12-20", "https://www.nasdaq.com/articles/why-celgene-agenus-and-incyte-jumped-today-2019-01-03", "https://www.nasdaq.com/articles/heres-why-agenus-shares-rose-much-135-today-2019-01-03", "https://www.nasdaq.com/articles/3-biotech-stocks-are-too-cheap-ignore-2018-12-26", "https://www.nasdaq.com/articles/agenus-shares-soar-after-cancer-therapy-deal-gilead-2018-12-20", "https://www.nasdaq.com/articles/us-futures-inch-higher-after-fed-move-2018-12-20", "https://www.nasdaq.com/articles/agen-soars-gild-deal-fenc-rolling-ahead-aimt-gaining-steam-2018-12-20", "https://www.nasdaq.com/articles/gilead-agenus-sign-deal-develop-immuno-oncology-therapies-2018-12-20", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-down-over-3-agenus-shares-spike-higher-2018-12-20", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-tumbles-400-points-dbv-technologies-shares-plummet-2018-12", "https://www.nasdaq.com/articles/why-is-agenus-agen-up-11.6-since-last-earnings-report-2018-12-06", "https://www.nasdaq.com/articles/heres-why-agenus-stock-popped-516-november-2018-12-05", "https://www.nasdaq.com/articles/agenus-agen-q3-loss-wider-than-expected-pipeline-in-focus-2018-11-08", "https://www.nasdaq.com/articles/agenus-agen-reports-q3-loss-tops-revenue-estimates-2018-11-06", "https://www.nasdaq.com/articles/will-agenus-agen-report-negative-earnings-next-week-what-you-should-know-2018-10-30", "https://www.nasdaq.com/articles/celyad-cyad-jumps%3A-stock-rises-6.8-2018-10-05", "https://www.nasdaq.com/articles/close-update-wall-street-roiled-possible-government-shutdown-fed-policy-moves-2018-12-20", "https://www.nasdaq.com/articles/health-care-sector-update-09212018-agen-xoma-lly-bgne-2018-09-21", "https://www.nasdaq.com/articles/health-care-sector-update-09212018-bgnexomaagenincymrk-2018-09-21", "https://www.nasdaq.com/articles/agenus-receives-milestone-payment-of-%245-million-from-incyte-2018-09-18", "https://www.nasdaq.com/articles/why-agenus-stock-perked-august-2018-09-07", "https://www.nasdaq.com/articles/agenus-agen-continue-to-surge-higher-2018-08-31", "https://www.nasdaq.com/articles/agenus-inc-stock-buy-2018-08-23", "https://www.nasdaq.com/articles/zacks.com-featured-highlights-include%3A-dollar-tree-agenus-huntsman-arcelormittal-and", "https://www.nasdaq.com/articles/amicus-therapeutics-fold-catches-eye%3A-stock-jumps-6.7-2018-10-04", "https://www.nasdaq.com/articles/health-care-sector-update-09212018-agen-xoma-lly-bgne-2018-09-21", "https://www.nasdaq.com/articles/agenus-agen-q2-loss-narrower-than-expected-revenues-beat-2018-08-10", "https://www.nasdaq.com/articles/agenus-agen-reports-q2-loss-lags-revenue-estimates-2018-08-09", "https://www.nasdaq.com/articles/agenus-agen-reports-narrower-expected-loss-q2-2018-08-09", "https://www.nasdaq.com/articles/will-agenus-agen-disappoint-investors-this-earnings-season-2018-07-30", "https://www.nasdaq.com/articles/should-biotech-investors-fear-dilution-2018-07-21", "https://www.nasdaq.com/articles/agenus-agen-down-1.5-since-earnings-report%3A-can-it-rebound-2018-06-06", "https://www.nasdaq.com/articles/step-beyond-bargain-hunting-tap-rising-pe-5-stocks-2018-08-16", "https://www.nasdaq.com/articles/agenus-agen-delivering-well-on-its-pipeline-candidates-2018-08-15", "https://www.nasdaq.com/articles/2-beaten-down-biotech-stocks-look-bargains-now-2018-05-05", "https://www.nasdaq.com/articles/will-agenus-agen-disappoint-investors-this-earnings-season-2018-04-30", "https://www.nasdaq.com/articles/why-is-agenus-agen-down-17.7-since-its-last-earnings-report-2018-04-16", "https://www.nasdaq.com/articles/agenus-agen-q4-loss-wider-than-expected-revenues-miss-2018-03-16", "https://www.nasdaq.com/articles/agenus-agen-reports-wider-than-expected-q4-loss-sales-miss-2018-03-15", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-15-2018-dg-btg-shen-adap-kpti-gco-tlp-agen-sup-jill-snd", "https://www.nasdaq.com/articles/agenus-inc-agen-buy-2018-05-12", "https://www.nasdaq.com/articles/why-agenus-stock-spiked-tuesday-2018-02-21", "https://www.nasdaq.com/articles/whats-in-store-for-agenus-agen-this-earnings-season-2018-02-21", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-agenus-agen-stock-2018-02-13", "https://www.nasdaq.com/articles/agenus-inc-buy-2018-02-13", "https://www.nasdaq.com/articles/spectrum-pharmaceuticals-up-134-in-6-months%3A-heres-why-2018-01-19", "https://www.nasdaq.com/articles/3-biotech-stocks-start-healthy-18-will-rally-last-2018-01-18", "https://www.nasdaq.com/articles/blackrock-pier-one-imports-alkermes-vertex-pharmaceuticals-and-agenus-highlighted-as-zacks", "https://www.nasdaq.com/articles/4-market-beating-sector-etfs-and-stocks-2018-02-28", "https://www.nasdaq.com/articles/agenus-inc.-agen-jumps%3A-stock-rises-11.4-2018-01-09", "https://www.nasdaq.com/articles/why-agenus-inc-stock-sank-december-2018-01-06", "https://www.nasdaq.com/articles/agenus-agen-reports-in-line-loss-in-q3-revenues-lag-2017-11-08", "https://www.nasdaq.com/articles/keryx-kerx-q3-loss-wider-than-expected-stock-declines-2017-11-08", "https://www.nasdaq.com/articles/prothena-prta-earnings-beat-in-q3-pipeline-in-focus-2017-11-08", "https://www.nasdaq.com/articles/agenus-agen-reports-in-line-q3-loss-sales-miss-estimates-2017-11-07", "https://www.nasdaq.com/articles/endocyte-ecyt-posts-narrower-than-expected-q3-loss-2017-11-07", "https://www.nasdaq.com/articles/will-2018-be-agenus-incs-best-year-yet-2018-01-16", "https://www.nasdaq.com/articles/whats-in-the-cards-for-merrimack-mack-in-q3-earnings-2017-11-06", "https://www.nasdaq.com/articles/whats-in-the-cards-for-repros-rprx-this-earnings-season-2017-11-06", "https://www.nasdaq.com/articles/whats-in-store-for-ligand-lgnd-this-earnings-season-2017-11-06", "https://www.nasdaq.com/articles/whats-in-store-for-madrigal-mdgl-this-earnings-season-2017-11-06", "https://www.nasdaq.com/articles/inovio-ino-q3-earnings%3A-is-a-beat-in-store-for-the-stock-2017-11-06", "https://www.nasdaq.com/articles/ironwood-irwd-beats-estimates-in-q3-earnings-stock-up-2017-11-03", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-perrigo-prgo-in-q3-earnings-2017-11-03", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2017-11-06", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-sales-beat-q3-estimates-2017-11-03", "https://www.nasdaq.com/articles/corcept-cort-q3-earnings-miss-estimates-guidance-raised-2017-11-03", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q3-earnings%3A-a-disappointment-in-store-revised-2017-11-02", "https://www.nasdaq.com/articles/epizyme-epzm-reports-narrower-than-expected-loss-in-q3-2017-11-02", "https://www.nasdaq.com/articles/zoetis-zts-beats-on-q3-earnings-sales-ups-2017-view-2017-11-02", "https://www.nasdaq.com/articles/geron-gern-q3-loss-narrower-than-expected-sales-miss-2017-11-02", "https://www.nasdaq.com/articles/sucampo-scmp-beats-on-q3-earnings-revenues-ups-17-view-2017-11-02", "https://www.nasdaq.com/articles/amag-pharmas-amag-q3-earnings-beat-lowers-17-outlook-2017-11-03", "https://www.nasdaq.com/articles/dr.-reddys-rdy-q2-earnings-and-revenues-decline-y-y-2017-11-01", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-ionis-ions-this-earnings-season-2017-11-01", "https://www.nasdaq.com/articles/novo-nordisk-nvo-tops-q3-earnings-estimates-lags-sales-2017-11-01", "https://www.nasdaq.com/articles/will-endocyte-ecyt-disappoint-this-earnings-season-2017-10-31", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-jazz-q3-earnings%3A-a-beat-in-store-2017-10-31", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-mylan-myl-this-earnings-season-2017-10-31", "https://www.nasdaq.com/articles/whats-in-the-cards-for-prothena-prta-in-q3-earnings-2017-10-31", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q3-earnings%3A-a-disappointment-in-store-2017-11-02", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-zoetis-zts-this-earnings-season-2017-10-30", "https://www.nasdaq.com/articles/is-a-turnaround-in-store-for-teva-teva-in-q3-earnings-2017-10-30", "https://www.nasdaq.com/articles/whats-in-the-cards-for-immune-design-imdz-in-q3-earnings-2017-10-30", "https://www.nasdaq.com/articles/whats-in-the-offing-for-intercept-icpt-in-q3-earnings-2017-10-30", "https://www.nasdaq.com/articles/whats-in-store-for-juno-therapeutics-juno-in-q3-earnings-2017-10-30", "https://www.nasdaq.com/articles/whats-in-the-cards-for-arena-arna-this-earnings-season-2017-10-30", "https://www.nasdaq.com/articles/what-to-expect-from-keryx-kerx-this-earnings-season-2017-10-31", "https://www.nasdaq.com/articles/alkermes-alks-beats-q3-earnings-estimates-cuts-sales-view-2017-10-27", "https://www.nasdaq.com/articles/sarepta-srpt-q3-loss-narrows-exondys-51-sales-view-raised-2017-10-26", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-agenus-agen-this-earnings-season-2017-10-25", "https://www.nasdaq.com/articles/why-agenus-inc-stock-briefly-popped-today-2017-10-23", "https://www.nasdaq.com/articles/why-agenus-inc-stock-slumped-today-2017-10-19", "https://www.nasdaq.com/articles/agenus-agen-remains-focused-on-drug-development-programs-2017-09-28", "https://www.nasdaq.com/articles/another-picks-and-shovels-nasdaq-stock-massive-potential-2017-09-14", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-immunogen-imgn-in-q3-earnings-2017-10-30", "https://www.nasdaq.com/articles/3-top-biotech-stocks-under-5-2017-08-19", "https://www.nasdaq.com/articles/3-beaten-biotech-stocks-are-they-bargains-2017-08-14", "https://www.nasdaq.com/articles/agenus-agen-q2-loss-narrower-than-expected-revenues-lag-2017-08-04", "https://www.nasdaq.com/articles/heres-why-agenus-inc-stock-slipped-136-july-2017-08-04", "https://www.nasdaq.com/articles/agenus-agen-reports-narrower-than-expected-q2-loss-2017-08-03", "https://www.nasdaq.com/articles/sucampo-scmp-q2-earnings-revenues-beat-estimates-up-y-y-2017-08-03", "https://www.nasdaq.com/articles/exact-sciences-corporation-exas-jumps%3A-stock-rises-6.2-2017-07-27", "https://www.nasdaq.com/articles/why-is-agenus-agen-down-11.8-since-the-last-earnings-report-2017-09-05", "https://www.nasdaq.com/articles/whats-in-store-for-endocyte-ecyt-this-earnings-season-2017-07-26", "https://www.nasdaq.com/articles/new-strong-buy-stocks-july-26th-2017-07-26", "https://www.nasdaq.com/articles/what-to-expect-from-international-paper-ip-in-q2-earnings-2017-07-25", "https://www.nasdaq.com/articles/sp-global-spgi-to-post-q2-earnings%3A-a-beat-in-the-cards-2017-07-25", "https://www.nasdaq.com/articles/vasco-vdsi-to-report-q2-earnings%3A-whats-in-the-offing-2017-07-25", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-agenus-agen-this-earnings-season-2017-07-24", "https://www.nasdaq.com/articles/what-to-expect-from-keryx-kerx-this-earnings-season-2017-07-21", "https://www.nasdaq.com/articles/did-checkpoint-inhibitor-bubble-just-burst-2017-07-27", "https://www.nasdaq.com/articles/new-strong-buy-stocks-july-20th-2017-07-20", "https://www.nasdaq.com/articles/uniqure-n.v.-qure-shows-strength%3A-stock-moves-9.1-higher-2017-07-20", "https://www.nasdaq.com/articles/agenus-agen-catches-eye%3A-stock-moves-up-8.7-in-session-2017-07-19", "https://www.nasdaq.com/articles/eiger-biopharmaceuticals-eigr-rises%3A-stock-climbs-24-2017-07-17", "https://www.nasdaq.com/articles/3-stocks-are-ridiculously-cheap-right-now-2017-07-16", "https://www.nasdaq.com/articles/alexion-reportedly-being-investigated-by-hhs-shares-slip-2017-07-07", "https://www.nasdaq.com/articles/vivus-settles-with-teva-on-weight-management-drug-generic-2017-07-06", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-alexion-alxn-this-earnings-season-2017-07-20", "https://www.nasdaq.com/articles/new-strong-buy-stocks-july-20th-2017-07-20", "https://www.nasdaq.com/articles/better-buy-agenus-inc-vs-kite-pharma-2017-07-02", "https://www.nasdaq.com/articles/agenus-agen-looks-good%3A-stock-moves-up-9.6-in-session-2017-06-21", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xbi-ixc-2017-06-20", "https://www.nasdaq.com/articles/agenus-agen-down-15.7-since-earnings-report%3A-can-it-rebound-2017-06-08", "https://www.nasdaq.com/articles/3-stocks-exelixis-return-potential-2017-06-05", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-goog-panw-agen-2017-05-30", "https://www.nasdaq.com/articles/geron-stock-up-almost-40-so-far-this-year-after-16-decline-2017-07-05", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-agenus-agen-stock-2017-07-03", "https://www.nasdaq.com/articles/heres-why-agenus-inc-stock-climbing-today-2017-05-04", "https://www.nasdaq.com/articles/whats-in-store-for-agenus-agen-this-earnings-season-2017-04-24", "https://www.nasdaq.com/articles/thursdays-etf-movers-xbi-gdxj-2017-04-13", "https://www.nasdaq.com/articles/thursday-413-insider-buying-report-hesm-agen-2017-04-13", "https://www.nasdaq.com/articles/why-is-agenus-agen-down-16.8-since-the-last-earnings-report-2017-04-11", "https://www.nasdaq.com/articles/better-buy-celldex-therapeutics-inc-vs-agenus-inc-2017-05-21", "https://www.nasdaq.com/articles/4-biotech-stocks-jaw-dropping-growth-potential-2017-03-21", "https://www.nasdaq.com/articles/agenus-agen-reports-narrower-than-expected-loss-in-q4-2017-03-10", "https://www.nasdaq.com/articles/better-buy-agenus-inc-vs-celldex-therapeutics-2017-03-10", "https://www.nasdaq.com/articles/agenus-agen-reports-narrower-than-expected-q4-loss-2017-03-09", "https://www.nasdaq.com/articles/agenus-agen%3A-whats-ahead-for-the-stock-in-q4-earnings-2017-02-27", "https://www.nasdaq.com/articles/troubling-trial-data-weighed-agenus-inc-stock-today-2017-02-22", "https://www.nasdaq.com/articles/agenus-agen-sharpens-focus-on-drug-development-programs-2017-04-05", "https://www.nasdaq.com/articles/health-care-sector-update-02142017-incyagencynoholxavir-2017-02-14", "https://www.nasdaq.com/articles/3-growth-stocks-could-double-2017-02-08", "https://www.nasdaq.com/articles/better-buy-agenus-inc-vs-alnylam-pharmaceuticals-inc-2017-02-06", "https://www.nasdaq.com/articles/forget-celldex-therapeutics-inc-these-2-stocks-are-better-buys-2017-02-01", "https://www.nasdaq.com/articles/agenus-nci-ink-deal-to-evaluate-prophage-keytruda-combo-2017-01-18", "https://www.nasdaq.com/articles/3-beaten-biotech-stocks-are-they-bargains-2016-12-09", "https://www.nasdaq.com/articles/agenus-incagn1876-in-phase-i-ii-study-for-solid-tumors-2016-12-01", "https://www.nasdaq.com/articles/why-agenus-stock-surging-today-2017-02-14", "https://www.nasdaq.com/articles/why-agenus-inc-stock-plummeted-447-october-2016-11-07", "https://www.nasdaq.com/articles/agenus-agen-reports-wider-than-expected-loss-in-q3-2016-10-28", "https://www.nasdaq.com/articles/agenus-agen-reports-narrower-than-expected-q3-loss-2016-10-27", "https://www.nasdaq.com/articles/why-fret-over-agenus-inc-q3-results-2016-10-27", "https://www.nasdaq.com/articles/agenus-agen%3A-whats-ahead-for-the-stock-in-q3-earnings-2016-10-24", "https://www.nasdaq.com/articles/better-buy-agenus-inc-vs-bellicum-pharmaceuticals-inc-2016-10-18", "https://www.nasdaq.com/articles/pfizers-latest-immunotherapy-deal-could-be-great-news-tiny-company-2016-09-27", "https://www.nasdaq.com/articles/3-red-flags-agenus-incs-balance-sheet-2016-11-23", "https://www.nasdaq.com/articles/car-t-isnt-only-play-immunotherapy-stocks-2016-09-07", "https://www.nasdaq.com/articles/2-cancer-therapy-stocks-are-ridiculously-cheap-right-now-2016-08-18", "https://www.nasdaq.com/articles/why-agenus-agen-stock-might-be-a-great-pick-2016-08-12", "https://www.nasdaq.com/articles/intercept-icpt-reports-narrower-than-expected-q2-loss-2016-08-08", "https://www.nasdaq.com/articles/will-agenus-agen-continue-to-surge-higher-2016-08-04", "https://www.nasdaq.com/articles/geron-gern-posts-narrower-expected-loss-q2-2016-08-04", "https://www.nasdaq.com/articles/aerie-aeri-q2-loss-wider-than-expected-pipeline-in-focus-2016-08-04", "https://www.nasdaq.com/articles/are-these-3-clinical-stage-biotechs-still-buys-after-soaring-august-2016-09-09", "https://www.nasdaq.com/articles/7-biotech-stocks-pivotal-catalysts-2017-2016-08-02", "https://www.nasdaq.com/articles/agenus-agen-posts-narrower-than-expected-loss-in-q2-2016-07-29", "https://www.nasdaq.com/articles/agenus-agen-reports-narrower-than-expected-q2-loss-2016-07-28", "https://www.nasdaq.com/articles/agenus-agen%3A-whats-ahead-for-the-stock-in-q2-earnings-2016-07-25", "https://www.nasdaq.com/articles/agenus-or-ariad-pharmaceuticals-better-long-term-buy-2016-07-19", "https://www.nasdaq.com/articles/why-agenus-stock-has-stumbled-2016-2016-06-27", "https://www.nasdaq.com/articles/better-buy-agenus-inc-vs-bluebird-bio-2016-06-24", "https://www.nasdaq.com/articles/abeona-therapeutics-abeo-in-focus%3A-stock-up-5.7-in-session-2016-08-03", "https://www.nasdaq.com/articles/2-biotech-stocks-under-5-jaw-dropping-growth-potential-2016-05-30", "https://www.nasdaq.com/articles/thursday-512-insider-buying-report-matr-agen-2016-05-12", "https://www.nasdaq.com/articles/agenus-agen-q1-loss-wider-than-expected-revenue-miss-2016-04-29", "https://www.nasdaq.com/articles/agenus-agen-reports-wider-than-expected-q1-loss-2016-04-28", "https://www.nasdaq.com/articles/either-analysts-got-components-wrong-or-russell-2000-headed-12-higher-2016-04-28", "https://www.nasdaq.com/articles/drug-stocks-earnings-previews%3A-kerx-bxlt-bmrn-agen-imgn-2016-04-27", "https://www.nasdaq.com/articles/agenus-agen-q1-earnings%3A-whats-in-store-for-the-stock-2016-04-25", "https://www.nasdaq.com/articles/should-pfizer-buy-beaten-down-immuno-oncology-company-2016-06-14", "https://www.nasdaq.com/articles/why-agenus-inc-flying-high-today-2016-03-11", "https://www.nasdaq.com/articles/agenus-q4-loss-in-line-with-estimates-revenues-impress-2016-03-04", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-march-4th-2016-03-04", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2016-03-03", "https://www.nasdaq.com/articles/agenus-reports-loss-beats-revenues-2016-03-03", "https://www.nasdaq.com/articles/forget-organovo-holdings-inc-these-2-stocks-are-better-buys-2016-03-01", "https://www.nasdaq.com/articles/whats-in-store-for-agenus-agen-this-earnings-season-2016-02-23", "https://www.nasdaq.com/articles/why-agenus-inc-stock-soared-43-march-2016-04-11", "https://www.nasdaq.com/articles/agenus-agen-catches-eye%3A-stock-adds-8.8-in-session-2016-01-22", "https://www.nasdaq.com/articles/why-shares-agenus-are-breaking-out-today-2016-01-21", "https://www.nasdaq.com/articles/big-firms-love-little-biotech-2016-01-03", "https://www.nasdaq.com/articles/agenus-acquires-phosimmune-adds-cancer-neoantigens-2015-12-28", "https://www.nasdaq.com/articles/3-biotech-stocks-under-5-could-explode-higher-2016-2015-12-27", "https://www.nasdaq.com/articles/3-stocks-we-not-retirees-2015-12-05", "https://www.nasdaq.com/articles/wednesdays-etf-movers-xbi-ilf-2015-11-25", "https://www.nasdaq.com/articles/how-id-invest-500-today-2016-02-13", "https://www.nasdaq.com/articles/agenus-q3-loss-wider-than-expected-pipeline-in-focus-2015-10-28", "https://www.nasdaq.com/articles/agenus-agen-q3-loss-is-wider-than-expected-2015-10-27", "https://www.nasdaq.com/articles/will-agenus-agen-disappoint-yet-again-in-q3-earnings-2015-10-26", "https://www.nasdaq.com/articles/wednesday-930-insider-buying-report-agen-jmp-2015-09-30", "https://www.nasdaq.com/articles/dont-panic-these-3-beaten-down-biotech-stocks-are-now-great-buys-2015-09-29", "https://www.nasdaq.com/articles/fridays-etf-unusual-volume-xbi-2015-09-25", "https://www.nasdaq.com/articles/fridays-etf-movers-rwx-xbi-2015-09-25", "https://www.nasdaq.com/articles/why-xoma-shares-are-crashing-2015-11-06", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-september-22nd-2015-09-22", "https://www.nasdaq.com/articles/why-agenus-stock-tumbled-august-2015-09-10", "https://www.nasdaq.com/articles/wall-street-cant-get-enough-speculative-biotech-stock-2015-09-03", "https://www.nasdaq.com/articles/incyte-hengrui-to-develop-anti-pd-1-monoclonal-antibody-2015-09-03", "https://www.nasdaq.com/articles/3-low-price-biotech-stocks-could-pop-or-drop-2016-2015-08-21", "https://www.nasdaq.com/articles/agenus-agen-reports-wider-than-expected-q2-loss-tale-of-the-tape-2015-07-23", "https://www.nasdaq.com/articles/will-agenus-agen-disappoint-investors-this-earnings-analyst-blog-2015-07-21", "https://www.nasdaq.com/articles/friday-sector-laggards-metals-mining-biotechnology-stocks-2015-09-25", "https://www.nasdaq.com/articles/why-agenus-agen-could-be-positioned-for-a-surge-tale-of-the-tape-2015-06-29", "https://www.nasdaq.com/articles/cancer-drugs-2-stocks-watch-2015-06-07", "https://www.nasdaq.com/articles/agenus-gains-after-merck-extends-immuno-oncology-ties-analyst-blog-2015-06-04", "https://www.nasdaq.com/articles/agenus-agen-provides-update-on-its-brain-cancer-vaccine-analyst-blog-2015-05-15", "https://www.nasdaq.com/articles/why-agenus-inc-shares-surged-higher-early-trading-today-2015-04-28", "https://www.nasdaq.com/articles/why-agenus-inc-shares-are-soaring-today-2015-04-24", "https://www.nasdaq.com/articles/eli-lilly-beats-1q-earnings-wide-margin-affirms-view-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/these-2-stocks-doubled-2015-1-still-buy-2015-07-18", "https://www.nasdaq.com/articles/immuno-oncology-best-area-biotech-invest-right-now-2015-04-22", "https://www.nasdaq.com/articles/will-agenus-agen-continue-to-surge-higher-tale-of-the-tape-2015-04-22", "https://www.nasdaq.com/articles/will-agenus-agen-disappoint-in-q1-earning-season-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2015-04-19", "https://www.nasdaq.com/articles/why-its-not-too-late-buy-agenus-inc-stock-2015-03-31", "https://www.nasdaq.com/articles/agenus-agen-reports-wider-than-expected-q4-loss-tale-of-the-tape-2015-02-26", "https://www.nasdaq.com/articles/notable-option-trades-equities-2015-02-09", "https://www.nasdaq.com/articles/agenus-agen-reports-wider-than-expected-q1-loss-tale-of-the-tape-2015-04-23", "https://www.nasdaq.com/articles/astrazeneca-inks-immuno-oncology-agreement-with-omnis-analyst-blog-2015-01-14", "https://www.nasdaq.com/articles/agenus-agen-worth-watching%3A-stock-soars-28.7-tale-of-the-tape-2015-01-12", "https://www.nasdaq.com/articles/agenus-soars-on-immuno-oncology-agreement-with-incyte-analyst-blog-2015-01-12", "https://www.nasdaq.com/articles/cancel-jpmorgan-plenty-pre-conference-data-and-deals-digest-2015-01-10", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-decline-infosys-posts-higher-profit-2015-01-09", "https://www.nasdaq.com/articles/us-stock-futures-edge-after-more-expected-jobs-added-economy-unemployment-drops-56-2015-01", "https://www.nasdaq.com/articles/us-futures-slip-ahead-jobs-report-2015-01-09", "https://www.nasdaq.com/articles/agenus-agen-shares-march-higher-can-it-continue-tale-of-the-tape-2015-01-16", "https://www.nasdaq.com/articles/astrazeneca-inks-immuno-oncology-agreement-with-omnis-analyst-blog-2015-01-14", "https://www.nasdaq.com/articles/mid-day-market-update-dow-dips-1-acuity-brands-shares-jump-earnings-beat-2015-01-09", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-12-29", "https://www.nasdaq.com/articles/agenus-agen-shares-march-higher-can-it-continue-tale-of-the-tape-2014-12-19", "https://www.nasdaq.com/articles/agenus-jumps-on-positive-data-from-shingles-candidate-analyst-blog-2014-12-19", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-12-08", "https://www.nasdaq.com/articles/mid-afternoon-market-update-five-below-slips-weak-outlook-agenus-shares-spike-higher-2015", "https://www.nasdaq.com/articles/fate-therapeutics-fate-catches-eye%3A-stock-adds-6.4-in-session-tale-of-the-tape-2014-11-19", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2014-11-18", "https://www.nasdaq.com/articles/keryx-kerx-in-focus%3A-stock-adds-11.9-in-session-tale-of-the-tape-2014-11-07", "https://www.nasdaq.com/articles/genomic-health-q3-loss-narrower-than-expected-revenues-lag-analyst-blog-2014-11-06", "https://www.nasdaq.com/articles/cytokinetics-incorporated-cytk-in-focus%3A-stock-surges-16.2-tale-of-the-tape-2014-11-05", "https://www.nasdaq.com/articles/achillion-pharmaceuticals-slumps%3A-achn-plunges-15.6-in-session-tale-of-the-tape-2014-11-05", "https://www.nasdaq.com/articles/integra-beats-earnings-sales-up-y-y-outlook-lowered-analyst-blog-2014-11-04", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-11-20", "https://www.nasdaq.com/articles/will-agenus-agen-incur-wider-than-expected-q3-loss-analyst-blog-2014-10-22", "https://www.nasdaq.com/articles/why-agenus-agen-could-be-positioned-for-a-slump-tale-of-the-tape-2014-08-05", "https://www.nasdaq.com/articles/agenus-inc.-agen-looks-strong-as-stock-surges-11.15-tale-of-the-tape-2014-07-25", "https://www.nasdaq.com/articles/sector-update-health-care-shares-higher-pre-market-2014-07-24", "https://www.nasdaq.com/articles/sector-update-health-care-2014-07-24-1", "https://www.nasdaq.com/articles/biodelivery-sciences-international-bdsi-rises%3A-stock-jumps-8.9-tale-of-the-tape-2014-07-08", "https://www.nasdaq.com/articles/oncolytics-biotech-inc.-oncy-in-focus%3A-stock-rises-9.5-tale-of-the-tape-2014-07-08", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-11-03", "https://www.nasdaq.com/articles/synta-pharmaceuticals-snta-jumps%3A-stock-rises-7.9-tale-of-the-tape-2014-07-07", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-07-03", "https://www.nasdaq.com/articles/agenus-up-on-positive-prophage-data-analyst-blog-2014-07-02", "https://www.nasdaq.com/articles/geron-corp.-gern-jumps%3A-stock-moves-8.1-higher-tale-of-the-tape-2014-07-01", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2014-07-01", "https://www.nasdaq.com/articles/sector-update-shares-flat-pre-market-agenus-soars-21-phase-2-trial-2014-07-01", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-07-01-1", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-07-07", "https://www.nasdaq.com/articles/synta-pharmaceuticals-snta-jumps%3A-stock-rises-7.9-tale-of-the-tape-2014-07-07", "https://www.nasdaq.com/articles/anthera-pharmaceuticals-anth-jumps%3A-stock-rises-10.3-tale-of-the-tape-2014-05-16", "https://www.nasdaq.com/articles/bluebird-bio-blue-jumps%3A-stock-adds-27.3-in-session-tale-of-the-tape-2014-05-15", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-soars%3A-stock-adds-26.9-in-session-tale-of-the-tape-2014-05-15", "https://www.nasdaq.com/articles/stock-market-news-for-april-29-2014-market-news-2014-04-29", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-04-24", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-acorda-could-file-patent-infringement-suit", "https://www.nasdaq.com/articles/positive-results-on-intercept-pharmas-oca-analyst-blog-2014-04-14", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-higher-pre-market-agenus-sinks-9-glaxcosmithkline-halts", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-04-02-0", "https://www.nasdaq.com/articles/agenus-agen-sees-hammer-chart-pattern%3A-time-to-buy-tale-of-the-tape-2014-03-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-gild-letter-triggers-major-selloff-analyst-blog-2014-03-26", "https://www.nasdaq.com/articles/why-agenus-agen-might-be-a-diamond-in-the-rough-tale-of-the-tape-2014-03-24", "https://www.nasdaq.com/articles/glaxos-mage-a3-candidate-disappoints-again-analyst-blog-2014-03-21", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-04-21", "https://www.nasdaq.com/articles/agenus-agen-jumps%3A-stock-adds-8.8-in-session-tale-of-the-tape-2014-01-10", "https://www.nasdaq.com/articles/agenus-agen-soars%3A-stock-adds-12.7-in-session-tale-of-the-tape-2013-12-17", "https://www.nasdaq.com/articles/healthcare-stocks-slightly-higher-agenus-adds-20-positive-test-results-prospective-cancer", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-16", "https://www.nasdaq.com/articles/transition-therapeutics-tthi-jumps%3A-stock-adds-7.0-in-session-tale-of-the-tape-2013-11-27", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-11-07", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-novabay-sheds-more-50-failure-meet-endpoint-2013-11", "https://www.nasdaq.com/articles/agenus-acquisition-4-antibody-transformational-move-2014-02-20", "https://www.nasdaq.com/articles/acordas-ggf2-in-another-study-analyst-blog-2013-10-14", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-agenus-10-malaria-vaccine-data-2013-10-08", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-08-1", "https://www.nasdaq.com/articles/acorda-progresses-with-pipeline-analyst-blog-2013-09-30", "https://www.nasdaq.com/articles/halozyme-halo-in-focus%3A-stock-rises-6.9-analyst-blog-2013-09-30", "https://www.nasdaq.com/articles/agenus-raises-funds-analyst-blog-2013-09-26", "https://www.nasdaq.com/articles/positive-results-on-agenus-candidate-analyst-blog-2013-09-18", "https://www.nasdaq.com/articles/qiagen-aids-genome-sequencing-study-analyst-blog-2013-10-16", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-agenus-rallies-22-phase-2-cancer-treatment-study-2013", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-09-17-1", "https://www.nasdaq.com/articles/agenus-upcoming-mage-3-clinical-trial-results-will-have-major-impact-stock-2013-08-21", "https://www.nasdaq.com/articles/agenus-key-clinical-events-are-imminent-2013-07-17", "https://www.nasdaq.com/articles/data-on-arqules-arq-092-analyst-blog-2013-04-10", "https://www.nasdaq.com/articles/spectrum-progresses-with-spi-2012-analyst-blog-2013-04-09", "https://www.nasdaq.com/articles/acorda-reports-data-on-epilepsy-drug-analyst-blog-2013-03-26", "https://www.nasdaq.com/articles/agenus-thoughts-phase-ii-results-prophage-glioblastoma-2013-09-18", "https://www.nasdaq.com/articles/xoma-posts-narrower-loss-analyst-blog-2013-03-14", "https://www.nasdaq.com/articles/spectrum-guides-lower-2013-revenue-analyst-blog-2013-03-13", "https://www.nasdaq.com/articles/update-on-elans-plans-analyst-blog-2013-03-11", "https://www.nasdaq.com/articles/acorda-presents-ggf2-data-analyst-blog-2013-03-08", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-osir-analyst-blog-2013-03-07", "https://www.nasdaq.com/articles/elan-to-share-tysabri-proceeds-analyst-blog-2013-03-07", "https://www.nasdaq.com/articles/aegerion-incurs-wider-loss-analyst-blog-2013-03-07", "https://www.nasdaq.com/articles/sppi-acquires-late-stage-candidate-analyst-blog-2013-03-18", "https://www.nasdaq.com/articles/wider-loss-at-intermune-analyst-blog-2013-02-22", "https://www.nasdaq.com/articles/savient-to-promote-sobis-kineret-analyst-blog-2013-02-21", "https://www.nasdaq.com/articles/aliof-candidate-approved-in-japan-analyst-blog-2013-02-20", "https://www.nasdaq.com/articles/zacks-rank-1-addition-for-thursday-tale-of-the-tape-2013-02-14", "https://www.nasdaq.com/articles/immunogen-progresses-with-imgn901-analyst-blog-2013-02-14", "https://www.nasdaq.com/articles/zacks-rank-1-addition-for-monday-tale-of-the-tape-2013-02-11", "https://www.nasdaq.com/articles/sgen-starts-sgn-cd19a-phase-i-study-analyst-blog-2013-02-07", "https://www.nasdaq.com/articles/vertex-flu-drug-shows-promise-analyst-blog-2013-03-06", "https://www.nasdaq.com/articles/data-on-anacor-candidate-analyst-blog-2013-01-30", "https://www.nasdaq.com/articles/threshold-merck-kgaa-drug-in-study-analyst-blog-2013-01-29", "https://www.nasdaq.com/articles/zacks-rank-1-addition-for-monday-tale-of-the-tape-2013-01-28", "https://www.nasdaq.com/articles/cadence-forecasts-ofirmev-sales-analyst-blog-2013-01-25", "https://www.nasdaq.com/articles/sgen-takedas-adcetris-progresses-analyst-blog-2013-01-25", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2013-01-24", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-friday-tale-of-the-tape-2013-01-18", "https://www.nasdaq.com/articles/zacks-rank-1-addition-for-wednesday-tale-of-the-tape-2013-02-06", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2013-01-14", "https://www.nasdaq.com/articles/celgene-remains-neutral-analyst-blog-2013-01-14", "https://www.nasdaq.com/articles/positive-results-on-mdcos-cangrelor-analyst-blog-2013-01-10", "https://www.nasdaq.com/articles/update-on-orexigens-contrave-analyst-blog-2013-01-10", "https://www.nasdaq.com/articles/biomarin-takes-over-zacharon-analyst-blog-2013-01-10", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2013-01-08", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2012-12-10", "https://www.nasdaq.com/articles/intermune-to-raise-funds-analyst-blog-2013-01-16", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-12-04", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-11-27", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-11-13", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2012-11-09", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2012-11-01", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2012-10-26", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-2-2012-apa-aee-anss-aria-apo-ale-ab-abmd-ayr-avd-arql", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2012-12-06", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2012-05-17", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2012-05-14", "https://www.nasdaq.com/articles/biotech-ideas-top-biotech-stocks-bullish-institutional-trends-2012-01-09", "https://www.nasdaq.com/articles/cancer-conference-trade-picking-biotech-bargains-2011-07-21", "https://www.nasdaq.com/articles/four-biotech-stocks-play-sector-pullback-2009-11-03", "https://www.nasdaq.com/articles/companys-first-profit-can-mean-big-gains-investors-screen-week-2012-07-17"], "Content": []}